You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. WayFinder: Cognitive Aid for Independent Transportation

    SBC: ABLELINK TECHNOLOGIES INC            Topic: N/A

    DESCRIPTION (provided by applicant): WAYFINDER: A Cognitive Aid for Independent Transportation ABSTRACT Transportation and mobility have long been areas of great dependency for individuals with intellectual disabilities, such as mental retardation. Few ind ividuals with intellectual disabilities obtain drivers licenses. Other typical modes of transit, such as taxi service, are prohibitive due to c ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  2. High Performance Carbon Nanomaterials for Electrochemical Capacitors

    SBC: ADA TECHNOLOGIES, INC.            Topic: 45

    Electrochemical capacitors are being developed for utility applications, providing emergency backup power, improving system stability, and lowering demand peaks. These functions reduce congestion at critical times for transmission and distribution systems. However, the use of electrochemical capacitors is limited by their performance (energy and power densities), safety, and short cycle life. T ...

    SBIR Phase I 2007 Department of Energy
  3. Conjugation Kits for Facile Preparation of Multivalent Glyco-nanoparticles

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Carbohydrate functionalized nanoparticles, i.e., the glyco-nanoparticles, have wide application ranging from studies of carbohydrate-protein interactions, in vivo cell imaging, biolabeling, cancer diagnostics, and to vaccine discovery. However, in comparison with DNA and protein functionalized nanoparticles, the development of glyco-nanoparticle has been left f ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  4. Novel 3-dimensional platform for high-throughput glycomics discovery

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Glycomics is an emerging field that focuses on studying the interactions of carbohydrates with other biopolymers, particularly proteins, to gain a better understanding of the roles of carbohydrates in biological processes. Carbohydrate microarray technologies represent a new development at the frontier of glycomics. Microarrays of carbohydrates (glycoconjugates ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  5. SBIR PHASE I: ANTIBODY MICROARRAY FOR CANCER BIOMARKER DETECTION

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  6. Alternative Reaction/Extraction Media to Reduce Energy and Cost of Biodiesel Production

    SBC: AEROPHASE, INC.            Topic: 07

    Worldwide fossil-fuel consumption is skyrocketing, creating major social, political, economic, and environmental problems for the US and once again throwing the spotlight upon the urgent need for boosting renewable energy sources, including biodiesel. However, key technical and economic challenges continue to make biodiesel fuel production too costly to compete with other liquid fuels, largely ba ...

    SBIR Phase I 2007 Department of Energy
  7. Low Cost Production of the Malaria Drug Artemether

    SBC: AEROPHASE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Malaria sickens over 100 million people each year. The vast majority of the victims live in endemic, tropical countries. Aggressive mosquito eradication programs in the 1940s essentially ended the incidence of locally-acquired malaria in the US, but resurgence remains a risk, so surveillance and research remain vital to US public health interests, as well as to ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  8. Protecting Polymers from the Natural Space Environment with Films Grown Using Atomic Layer Deposition

    SBC: ALD NANOSOLUTIONS, INC            Topic: AF07T011

    Polymers and paints in space are subjected to a barrage of incident oxygen atoms, UV and VUV photons and ions. The oxygen atoms and photons can erode the polymer and the ions can lead to the buildup of static charge. This Phase I proposal will use atomic layer deposition (ALD) methods to coat polymers with various conformal films to protect the polymer and prevent the buildup of static charge. ...

    STTR Phase I 2007 Department of DefenseAir Force
  9. A Real-Time, Label-Free Diagnostic Platform with Glycan Arrays

    SBC: BIOPTIX DIAGNOSTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The ultimate goal of the proposed work is to develop a compact, label free, sensitive and real-time platform capable of multiplex detection of biomarkers and pathogens using glycan microarrays. Glycans, which are predominant surface components of immune cells and microorganisms, give rise to high levels of anti-glycan antibodies of all classes that can be used ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  10. Improving the Transfer of ERK siRNA Constructs Using Nanoporous Silica

    SBC: APOLLO SRI, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Our research is focused on the potential of acid-prepared mesoporous silica (APMS) as a delivery agent for siRNA constructs to inhibit the ERK1/2 and ERK5 pathways in the treatment of human malignant mesothelioma (MM). These pathways are critical to MM cell proliferation and chemoresistance. Our initial research suggests that APMS will be significantly more eff ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government